BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Masias C, Cataland SR. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood 2018;132:903-10. [PMID: 30006329 DOI: 10.1182/blood-2018-02-791533] [Cited by in Crossref: 22] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Liang SJ, Zheng QY, Li MS, Lv MY, Chen WT, Yang Y. Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review. Clin Rheumatol 2022. [PMID: 35524885 DOI: 10.1007/s10067-022-06155-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Albo Z, Mathew C, Catton R, Silver B, Moonis M. Thrombotic Thrombocytopenic Purpura (ADAMTS13 [a Disintegrin and Metalloproteinase With a Thrombospondin Type 1 Motif, Member 13] Deficiency) as Cause of Recurrent Multiterritory Ischemic Strokes. Stroke 2022;53:e237-40. [PMID: 35341321 DOI: 10.1161/STROKEAHA.121.034434] [Reference Citation Analysis]
3 Zhou S, Guo J, Liao X, Zhou Q, Qiu X, Jiang S, Xu N, Wang X, Zhao L, Hu W, Xie L, Xie P, Cui Y, Yang Y, Patzak A, Persson PB, Mao J, Lai EY. rhADAMTS13 reduces oxidative stress by cleaving VWF in ischaemia/reperfusion-induced acute kidney injury. Acta Physiol (Oxf) 2022;234:e13778. [PMID: 34989474 DOI: 10.1111/apha.13778] [Reference Citation Analysis]
4 Hafez W, Ziade MA, Arya A, Saleh H, Ali S, Rao SR, Alla OF, Ali M, Zouhbi MA, Abdelrahman A. Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19; A Retrospective Observational Study. Int J Infect Dis 2022:S1201-9712(22)00097-2. [PMID: 35167969 DOI: 10.1016/j.ijid.2022.02.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Subhan M, Scully M. Advances in the management of TTP. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Qiao R, Xiao R, Chen Z, Jiang J, Yuan C, Ning S, Wang J, Zhou Z. Cloning, Expression and Inhibitory Effects on Lewis Lung Carcinoma Cells of rAj-Tspin from Sea Cucumber (Apostichopus japonicus). Molecules 2021;27:229. [PMID: 35011462 DOI: 10.3390/molecules27010229] [Reference Citation Analysis]
7 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Sun S, Urbanus RT, ten Cate H, de Groot PG, de Laat B, Heemskerk JWM, Roest M. Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia. Cells 2021;10:3386. [DOI: 10.3390/cells10123386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
9 Sukumar S, Gavriilaki E, Chaturvedi S. Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship. Thrombosis Update 2021;5:100062. [DOI: 10.1016/j.tru.2021.100062] [Reference Citation Analysis]
10 Pavenski K, Huang SS, Patriquin CJ. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura. Expert Rev Hematol 2021;:1-14. [PMID: 34747320 DOI: 10.1080/17474086.2021.2003703] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Li P, Jiang J, Xi Q, Yang Z. An ADAMTS13 mutation that causes hereditary thrombotic thrombocytopenic purpura: a case report and literature review. BMC Med Genomics 2021;14:252. [PMID: 34702267 DOI: 10.1186/s12920-021-01099-3] [Reference Citation Analysis]
12 Meng X, Huang W, Mo W, Shu T, Yang H, Ning H. ADAMTS-13-regulated nuclear factor E2-related factor 2 signaling inhibits ferroptosis to ameliorate cisplatin-induced acute kidney injuy. Bioengineered 2021. [PMID: 34666603 DOI: 10.1080/21655979.2021.1994707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Di Micco P, Camporese G, Cardillo G, Lodigiani C, Carannante N, Annunziata A, Fiorentino G, Russo V, Imbalzano E. Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency. Medicina (Kaunas) 2021;57:997. [PMID: 34684034 DOI: 10.3390/medicina57100997] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Thomazini CM, Sachetto ATA, de Albuquerque CZ, de Moura Mattaraia VG, de Oliveira AK, Serrano SMT, Lebrun I, Barbaro KC, Santoro ML. Involvement of von Willebrand factor and botrocetin in the thrombocytopenia induced by Bothrops jararaca snake venom. PLoS Negl Trop Dis 2021;15:e0009715. [PMID: 34478462 DOI: 10.1371/journal.pntd.0009715] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Francischetti IMB, Toomer K, Zhang Y, Jani J, Siddiqui Z, Brotman DJ, Hooper JE, Kickler TS. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection. EClinicalMedicine 2021;39:101069. [PMID: 34377969 DOI: 10.1016/j.eclinm.2021.101069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
16 Huang S, Ninivaggi M, Chayoua W, de Laat B. VWF, Platelets and the Antiphospholipid Syndrome. Int J Mol Sci 2021;22:4200. [PMID: 33919627 DOI: 10.3390/ijms22084200] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Matsumoto H, Takeba J, Umakoshi K, Kikuchi S, Ohshita M, Annen S, Moriyama N, Nakabayashi Y, Sato N, Aibiki M. ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational study. Thromb J 2021;19:17. [PMID: 33712048 DOI: 10.1186/s12959-021-00270-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Browning S, Bahar B, Lee AI, Gorshein E. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state. Hematology 2020;25:473-7. [PMID: 33269995 DOI: 10.1080/16078454.2020.1848973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sukumar S, Lämmle B, Cataland SR. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J Clin Med 2021;10:536. [PMID: 33540569 DOI: 10.3390/jcm10030536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
20 Mori F, Nardini I, Caricasole A, Amega NS, Farina C. Characterization of a plasma-derived double-viral-inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment. Haemophilia 2021;27:e409-11. [PMID: 33529361 DOI: 10.1111/hae.14260] [Reference Citation Analysis]
21 Ladeira VS, Barbosa AR, Oliveira MM, Ferreira LGR, de Oliveira Júnior WV, de Oliveira Renó C, Reis EA, Chaves DG, Dusse LMS, Dos Santos HL, de Barros Pinheiro M, Rios DRA. ADAMTS-13-VWF axis in sickle cell disease patients. Ann Hematol 2021;100:375-82. [PMID: 33404693 DOI: 10.1007/s00277-020-04385-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Zhu ML, Reeves HM, Maitta RW. Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura. Thromb Res 2021;198:72-8. [PMID: 33290885 DOI: 10.1016/j.thromres.2020.11.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Kundrapu S, Reeves HM, Maitta RW. Absolute Immature Platelet Counts Suggest Platelet Production Suppression during Complicated Relapsing Thrombotic Thrombocytopenic Purpura. Acta Haematol 2021;144:465-9. [PMID: 33238282 DOI: 10.1159/000510913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Piedrafita A, Ribes D, Cointault O, Chauveau D, Faguer S, Huart A. Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice. Transfus Apher Sci 2020;59:102990. [PMID: 33272850 DOI: 10.1016/j.transci.2020.102990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Montaruli B, Novelli C, Solfietti L, Valpreda A, Bazzan M, Luigi Andrea Beverina I, Brando B, Roccatello D, Cosseddu D. Inhibitory anti ADAMTS13 antibodies with a new rapid fully automated CLiA assay. Int J Lab Hematol 2021;43:298-304. [PMID: 33095979 DOI: 10.1111/ijlh.13372] [Reference Citation Analysis]
26 Xu Z, Luo C, Lai P, Ling W, Wu S, Huang X, Huang L, Zhang G, Du X, Weng J. von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy. Clin Appl Thromb Hemost 2020;26:1076029619892684. [PMID: 32088973 DOI: 10.1177/1076029619892684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Krecak I, Medic MG, Gveric-Krecak V, Roncevic P, Bašić Kinda S, Babel J, Radonic R. Coombs-positive refractory acquired thrombotic thrombocytopenic purpura in a patient with chronic myelomonocytic leukemia successfully treated with rituximab. Acta Clin Belg 2020;75:357-61. [PMID: 31007140 DOI: 10.1080/17843286.2019.1608395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Kucukyurt S, Eskazan AE. Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes. J Blood Med 2020;11:319-26. [PMID: 33061729 DOI: 10.2147/JBM.S205630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Dai YL, Tang X, Chen HB, Peng QY, Guo X, Gao J. Hereditary Thrombotic Thrombocytopenic Purpura in a Chinese Boy With a Novel Compound Heterozygous Mutation of the ADAMTS13 Gene. Front Pediatr 2020;8:554. [PMID: 33014938 DOI: 10.3389/fped.2020.00554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tiscia GL, Favuzzi G, De Laurenzo A, Cappucci F, Fischetti L, di Mauro L, Miscio G, Mirijello A, Chinni E, Grandone E; CSS COVID-19 Group . Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients. TH Open 2020;4:e203-6. [PMID: 32879905 DOI: 10.1055/s-0040-1716379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
31 Mackie I, Mancini I, Muia J, Kremer Hovinga J, Nair S, Machin S, Baker R. International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13. Int J Lab Hem 2020;42:685-96. [DOI: 10.1111/ijlh.13295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
32 Morici N, Bottiroli M, Fumagalli R, Marini C, Cattaneo M. Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink. Thromb Haemost 2020;120:1339-42. [PMID: 32575136 DOI: 10.1055/s-0040-1713400] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
33 Wang XY, Liu XF, Xue F, Liu W, Chen YF, Huang YT, Fu RF, Zhang L, Yang RC. [Clinical characteristics of 83 patients with thrombotic thrombocytopenic purpura]. Zhonghua Xue Ye Xue Za Zhi 2020;41:216-21. [PMID: 32311891 DOI: 10.3760/cma.j.issn.0253-2727.2020.03.006] [Reference Citation Analysis]
34 Tang N, Wang X, Li D, Sun Z. Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients. Thrombosis Research 2018;172:9-13. [DOI: 10.1016/j.thromres.2018.10.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]